Article
A blood DNA methylation biomarker for predicting short-term risk of cardiovascular events
2022-06-02
Abstract excerpt
<h4>Background: </h4> Recent evidence highlights the epidemiological value of blood DNA methylation (DNAm) as surrogate biomarker for exposures to risk factors for non-communicable diseases (NCD). DNAm surrogate of exposures predict diseases and longevity better than self-reported or measured exposures in many cases. Consequently, disease prediction models based on blood DNAm surrogates may outperform current stat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b3ed9b33-bdeb-595f-a5b8-720b39248956
- DOI
- 10.21203/rs.3.rs-1689354/v1